Clinical Trial Detail

NCT ID NCT02384239
Title A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of California, San Francisco
Indications

breast cancer

Her2-receptor negative breast cancer

Therapies

Fulvestrant + Palbociclib

Palbociclib + Tamoxifen

Age Groups: adult senior

Additional content available in CKB BOOST